Activated PI3 kinase delta syndrome

5 trials MedDRA PT
5 Registered trials
0 Recruiting
1 Unique sponsors
1 Unique IMPs
5 Commercial trials
Drug classes (ATC)
— ATC code not specified 5
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Phase III: 2 Phase I (Other): 3

Filter these 5 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 5 trials

Phase III

2 trials
  • Pharming Technologies B.V. Commercial
    LENIOLISIB PHOSPHATE
    2022-502180-38-00 2 countries 2024 n=4 Orphan
    Ended
  • Pharming Technologies B.V. Commercial
    LENIOLISIB PHOSPHATE
    2024-515489-15-00 1 country 2023 n=6 Orphan
    Ended

Phase I (Other)

3 trials
  • Pharming Technologies B.V. Commercial
    IMP not specified
    2023-507134-25-00 1 country 2024 n=20
    Ended
  • Pharming Technologies B.V. Commercial
    IMP not specified
    2023-508519-22-00 2 countries 2024 n=48
    Ended
  • Pharming Technologies B.V. Commercial
    LENIOLISIB PHOSPHATE
    2023-508880-61-00 1 country 2024 n=18 Orphan
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Pharming Technologies B.V. Commercial 5 Phase I (Other), Phase III 0
New trials by year
2023
1
2024
4
← All indication landscapes